TB-500 Fragment (17-23), also known as Fequesetide or Thymosin Beta-4 Fragment (17-23), is a synthetic seven-amino-acid peptide corresponding to the actin-binding domain of the naturally occurring Thymosin Beta-4 protein. The peptide sequence LKKTETQ has been extensively utilized in biochemical and molecular biology laboratories for investigating peptide–protein interactions, cytoskeletal dynamics, and related cellular mechanisms.
Produced using advanced solid-phase peptide synthesis (SPPS) technology, our TB-500 Fragment is manufactured under rigorous quality control procedures to ensure high purity, excellent stability, and reproducible batch-to-batch consistency. Each production batch is verified by HPLC and Mass Spectrometry (MS), with supporting analytical documents available upon request.
This product is intended exclusively for laboratory research, including:
Store at 2–8°C for short-term storage. For long-term preservation, keep at -20°C in a sealed container protected from moisture, heat, and direct light.
Each batch undergoes comprehensive analytical testing, including:
COA, HPLC chromatogram, and MS reports are available upon request.
This product is intended for laboratory research purposes only. It is not intended for human or veterinary use, diagnostic procedures, therapeutic applications, or clinical use. Researchers should handle this material using appropriate laboratory safety practices.